avrg: SARS-CoV-2 Analysis Results (GEO series: GSE147507)
Name | miRBASE accession |
---|---|
hsa-miR-9-5p
|
MIMAT0000441 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.5 | 4.5 | GO:0002276 | basophil activation involved in immune response(GO:0002276) |
0.9 | 3.5 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.7 | 2.0 | GO:0003365 | establishment of cell polarity involved in ameboidal cell migration(GO:0003365) |
0.7 | 1.3 | GO:1904339 | negative regulation of dopaminergic neuron differentiation(GO:1904339) |
0.6 | 1.9 | GO:0008057 | eye pigment granule organization(GO:0008057) |
0.6 | 2.4 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.5 | 1.6 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
0.5 | 3.9 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.5 | 0.9 | GO:0061184 | positive regulation of dermatome development(GO:0061184) |
0.5 | 1.4 | GO:2001226 | negative regulation of chloride transport(GO:2001226) |
0.5 | 3.2 | GO:0035795 | negative regulation of mitochondrial membrane permeability(GO:0035795) |
0.4 | 3.1 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.4 | 0.8 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.4 | 1.1 | GO:1903452 | regulation of G1 to G0 transition(GO:1903450) positive regulation of G1 to G0 transition(GO:1903452) |
0.4 | 2.5 | GO:0035879 | plasma membrane lactate transport(GO:0035879) |
0.3 | 2.4 | GO:0070417 | cellular response to cold(GO:0070417) |
0.3 | 1.6 | GO:1904450 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) aspartate secretion(GO:0061528) regulation of aspartate secretion(GO:1904448) positive regulation of aspartate secretion(GO:1904450) |
0.3 | 1.2 | GO:0048698 | negative regulation of collateral sprouting in absence of injury(GO:0048698) |
0.3 | 1.2 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.3 | 1.5 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) regulation of natural killer cell degranulation(GO:0043321) positive regulation of natural killer cell degranulation(GO:0043323) |
0.3 | 1.2 | GO:0086092 | regulation of the force of heart contraction by cardiac conduction(GO:0086092) |
0.3 | 1.1 | GO:0035978 | mesodermal-endodermal cell signaling(GO:0003131) programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) histone H2A-S139 phosphorylation(GO:0035978) positive regulation of cellular response to X-ray(GO:2000685) |
0.3 | 0.8 | GO:0045994 | positive regulation of translational initiation by iron(GO:0045994) |
0.3 | 2.4 | GO:0003383 | apical constriction(GO:0003383) |
0.3 | 1.3 | GO:0019319 | hexose biosynthetic process(GO:0019319) |
0.2 | 0.7 | GO:0034970 | histone H3-R2 methylation(GO:0034970) |
0.2 | 1.2 | GO:0015917 | aminophospholipid transport(GO:0015917) |
0.2 | 0.7 | GO:0048210 | Golgi vesicle fusion to target membrane(GO:0048210) |
0.2 | 1.3 | GO:0090283 | regulation of protein glycosylation in Golgi(GO:0090283) |
0.2 | 0.7 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.2 | 1.3 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
0.2 | 1.5 | GO:0072674 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
0.2 | 1.1 | GO:0032796 | uropod organization(GO:0032796) |
0.2 | 2.2 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.2 | 0.6 | GO:0034402 | recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex(GO:0034402) |
0.2 | 0.6 | GO:0018008 | N-terminal peptidyl-glycine N-myristoylation(GO:0018008) |
0.2 | 0.6 | GO:0002661 | B cell tolerance induction(GO:0002514) regulation of B cell tolerance induction(GO:0002661) positive regulation of B cell tolerance induction(GO:0002663) |
0.2 | 0.8 | GO:0048936 | visceral motor neuron differentiation(GO:0021524) peripheral nervous system neuron axonogenesis(GO:0048936) cardiac cell fate determination(GO:0060913) positive regulation of granulocyte colony-stimulating factor production(GO:0071657) positive regulation of macrophage colony-stimulating factor production(GO:1901258) |
0.2 | 0.6 | GO:1902559 | 3'-phosphoadenosine 5'-phosphosulfate transport(GO:0046963) 3'-phospho-5'-adenylyl sulfate transmembrane transport(GO:1902559) |
0.2 | 2.2 | GO:0090232 | positive regulation of spindle checkpoint(GO:0090232) |
0.2 | 0.7 | GO:0046684 | response to pyrethroid(GO:0046684) |
0.2 | 0.5 | GO:0048627 | myoblast development(GO:0048627) |
0.2 | 1.3 | GO:1904381 | Golgi apparatus mannose trimming(GO:1904381) |
0.2 | 0.4 | GO:0038109 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
0.2 | 0.5 | GO:0001544 | initiation of primordial ovarian follicle growth(GO:0001544) |
0.2 | 1.4 | GO:1903826 | arginine transmembrane transport(GO:1903826) |
0.2 | 0.8 | GO:0090118 | receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
0.2 | 0.5 | GO:0061386 | closure of optic fissure(GO:0061386) |
0.2 | 0.5 | GO:1990051 | activation of protein kinase C activity(GO:1990051) |
0.2 | 2.4 | GO:0071681 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.2 | 0.5 | GO:1904693 | midbrain morphogenesis(GO:1904693) |
0.2 | 0.3 | GO:0061145 | bronchus cartilage development(GO:0060532) lung smooth muscle development(GO:0061145) |
0.2 | 0.5 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.2 | 2.6 | GO:0035878 | nail development(GO:0035878) |
0.2 | 1.1 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.2 | 4.7 | GO:0034389 | lipid particle organization(GO:0034389) |
0.1 | 0.6 | GO:0003344 | pericardium morphogenesis(GO:0003344) |
0.1 | 0.6 | GO:1903778 | protein localization to vacuolar membrane(GO:1903778) |
0.1 | 1.0 | GO:0015798 | myo-inositol transport(GO:0015798) |
0.1 | 0.7 | GO:0043335 | protein unfolding(GO:0043335) |
0.1 | 1.3 | GO:2000065 | negative regulation of aldosterone metabolic process(GO:0032345) negative regulation of aldosterone biosynthetic process(GO:0032348) negative regulation of cortisol biosynthetic process(GO:2000065) |
0.1 | 0.7 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.1 | 0.9 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.1 | 0.6 | GO:0016094 | polyprenol biosynthetic process(GO:0016094) |
0.1 | 0.6 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.1 | 1.0 | GO:1903385 | regulation of homophilic cell adhesion(GO:1903385) |
0.1 | 0.4 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.1 | 4.2 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.1 | 0.5 | GO:0002384 | hepatic immune response(GO:0002384) |
0.1 | 2.2 | GO:0060413 | atrial septum morphogenesis(GO:0060413) |
0.1 | 1.4 | GO:0060174 | limb bud formation(GO:0060174) |
0.1 | 0.6 | GO:2000312 | regulation of kainate selective glutamate receptor activity(GO:2000312) |
0.1 | 0.6 | GO:0090650 | response to oxygen-glucose deprivation(GO:0090649) cellular response to oxygen-glucose deprivation(GO:0090650) |
0.1 | 4.8 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.1 | 1.8 | GO:0060346 | bone trabecula formation(GO:0060346) |
0.1 | 1.0 | GO:1904885 | beta-catenin destruction complex assembly(GO:1904885) |
0.1 | 3.4 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.1 | 1.2 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.1 | 1.5 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.1 | 0.7 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.1 | 0.5 | GO:1904808 | regulation of protein oxidation(GO:1904806) positive regulation of protein oxidation(GO:1904808) |
0.1 | 1.7 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.1 | 0.3 | GO:2000687 | negative regulation of rubidium ion transport(GO:2000681) negative regulation of rubidium ion transmembrane transporter activity(GO:2000687) |
0.1 | 0.4 | GO:1904978 | regulation of endosome organization(GO:1904978) |
0.1 | 0.7 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
0.1 | 2.1 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
0.1 | 0.3 | GO:0070781 | response to biotin(GO:0070781) |
0.1 | 2.5 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.1 | 0.4 | GO:1905007 | positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation(GO:1905007) |
0.1 | 0.7 | GO:0071971 | extracellular exosome assembly(GO:0071971) regulation of extracellular exosome assembly(GO:1903551) |
0.1 | 1.2 | GO:0034626 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.1 | 1.0 | GO:1901315 | negative regulation of histone ubiquitination(GO:0033183) regulation of histone H2A K63-linked ubiquitination(GO:1901314) negative regulation of histone H2A K63-linked ubiquitination(GO:1901315) |
0.1 | 1.4 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) |
0.1 | 1.1 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.1 | 0.8 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.1 | 0.4 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.1 | 0.3 | GO:0032904 | viral protein processing(GO:0019082) regulation of nerve growth factor production(GO:0032903) negative regulation of nerve growth factor production(GO:0032904) dibasic protein processing(GO:0090472) |
0.1 | 1.9 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.1 | 0.6 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.1 | 0.7 | GO:0030578 | PML body organization(GO:0030578) |
0.1 | 0.3 | GO:0051389 | inactivation of MAPKK activity(GO:0051389) |
0.1 | 1.8 | GO:2001197 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
0.1 | 0.8 | GO:0031087 | deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.1 | 0.5 | GO:1904222 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.1 | 1.5 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.1 | 0.9 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
0.1 | 0.8 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.1 | 0.5 | GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
0.1 | 0.6 | GO:0060235 | lens induction in camera-type eye(GO:0060235) |
0.1 | 0.2 | GO:0001579 | medium-chain fatty acid transport(GO:0001579) |
0.1 | 1.3 | GO:0015866 | ADP transport(GO:0015866) |
0.1 | 0.3 | GO:0034721 | histone H3-K4 demethylation, trimethyl-H3-K4-specific(GO:0034721) |
0.1 | 1.0 | GO:0002553 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
0.1 | 1.0 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
0.1 | 1.8 | GO:0060211 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
0.1 | 0.6 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.1 | 1.4 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.1 | 0.3 | GO:0035574 | histone H4-K20 demethylation(GO:0035574) |
0.1 | 0.5 | GO:0021691 | cerebellar Purkinje cell layer maturation(GO:0021691) |
0.1 | 0.5 | GO:0003408 | optic cup formation involved in camera-type eye development(GO:0003408) |
0.1 | 0.2 | GO:1904017 | cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
0.1 | 0.9 | GO:1904352 | positive regulation of protein catabolic process in the vacuole(GO:1904352) |
0.1 | 1.0 | GO:1990416 | cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
0.1 | 0.7 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.1 | 0.2 | GO:0044313 | protein K6-linked deubiquitination(GO:0044313) |
0.1 | 0.1 | GO:0016340 | calcium-dependent cell-matrix adhesion(GO:0016340) |
0.1 | 0.3 | GO:0097045 | phosphatidylserine exposure on blood platelet(GO:0097045) |
0.1 | 1.2 | GO:0070166 | enamel mineralization(GO:0070166) |
0.1 | 1.0 | GO:0060613 | fat pad development(GO:0060613) |
0.1 | 1.6 | GO:0034656 | nucleobase-containing small molecule catabolic process(GO:0034656) |
0.1 | 0.7 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.1 | 0.6 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.1 | 1.0 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.1 | 0.3 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
0.1 | 0.3 | GO:1903070 | negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
0.1 | 0.4 | GO:0050428 | purine ribonucleoside bisphosphate biosynthetic process(GO:0034036) 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process(GO:0050428) |
0.1 | 0.4 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
0.1 | 0.9 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.1 | 0.6 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.1 | 0.4 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.1 | 1.8 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
0.1 | 0.8 | GO:0015705 | iodide transport(GO:0015705) |
0.1 | 0.3 | GO:2000645 | negative regulation of receptor catabolic process(GO:2000645) |
0.1 | 0.6 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.1 | 1.7 | GO:0097320 | membrane tubulation(GO:0097320) |
0.1 | 1.0 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.1 | 0.2 | GO:0018352 | protein-pyridoxal-5-phosphate linkage(GO:0018352) |
0.1 | 0.2 | GO:0019085 | early viral transcription(GO:0019085) |
0.1 | 0.7 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.1 | 0.4 | GO:0090063 | positive regulation of microtubule nucleation(GO:0090063) |
0.1 | 1.5 | GO:0031116 | positive regulation of microtubule polymerization(GO:0031116) |
0.0 | 0.5 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.0 | 0.1 | GO:0071284 | cellular response to lead ion(GO:0071284) |
0.0 | 0.4 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.0 | 1.0 | GO:1901215 | negative regulation of neuron death(GO:1901215) |
0.0 | 0.2 | GO:0031291 | Ran protein signal transduction(GO:0031291) |
0.0 | 1.9 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
0.0 | 0.7 | GO:0043923 | positive regulation by host of viral transcription(GO:0043923) |
0.0 | 0.1 | GO:0036451 | cap mRNA methylation(GO:0036451) |
0.0 | 0.3 | GO:0072423 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) |
0.0 | 0.1 | GO:0045083 | negative regulation of interleukin-12 biosynthetic process(GO:0045083) |
0.0 | 0.3 | GO:0035977 | protein deglycosylation involved in glycoprotein catabolic process(GO:0035977) glycoprotein ERAD pathway(GO:0097466) mannose trimming involved in glycoprotein ERAD pathway(GO:1904382) |
0.0 | 0.4 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.0 | 0.6 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.0 | 0.6 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.0 | 0.2 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.0 | 0.3 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.0 | 1.4 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.0 | 0.8 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
0.0 | 1.4 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
0.0 | 0.2 | GO:0070459 | prolactin secretion(GO:0070459) |
0.0 | 0.5 | GO:0015871 | choline transport(GO:0015871) |
0.0 | 0.2 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.0 | 1.1 | GO:0015695 | organic cation transport(GO:0015695) |
0.0 | 0.8 | GO:0023019 | signal transduction involved in regulation of gene expression(GO:0023019) |
0.0 | 0.2 | GO:0043686 | co-translational protein modification(GO:0043686) |
0.0 | 0.3 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
0.0 | 0.6 | GO:0001682 | tRNA 5'-leader removal(GO:0001682) |
0.0 | 0.6 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.0 | 0.2 | GO:0006172 | ADP biosynthetic process(GO:0006172) |
0.0 | 0.4 | GO:0045176 | apical protein localization(GO:0045176) |
0.0 | 0.4 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.0 | 0.7 | GO:0021511 | spinal cord patterning(GO:0021511) |
0.0 | 0.1 | GO:0045226 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.0 | 0.4 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.0 | 0.9 | GO:0044705 | mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
0.0 | 0.6 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.0 | 2.0 | GO:2000142 | regulation of DNA-templated transcription, initiation(GO:2000142) |
0.0 | 0.1 | GO:0086097 | microspike assembly(GO:0030035) phospholipase C-activating angiotensin-activated signaling pathway(GO:0086097) positive regulation of endocytic recycling(GO:2001137) |
0.0 | 0.8 | GO:0006907 | pinocytosis(GO:0006907) |
0.0 | 0.5 | GO:2000780 | negative regulation of double-strand break repair(GO:2000780) |
0.0 | 0.3 | GO:0070777 | sulfur amino acid transport(GO:0000101) D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.0 | 0.8 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.0 | 0.2 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.0 | 0.1 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.0 | 0.8 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
0.0 | 0.3 | GO:0046852 | positive regulation of bone resorption(GO:0045780) positive regulation of bone remodeling(GO:0046852) |
0.0 | 0.2 | GO:0060215 | primitive hemopoiesis(GO:0060215) |
0.0 | 0.4 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.0 | 0.7 | GO:0043090 | amino acid import(GO:0043090) |
0.0 | 1.3 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.0 | 0.2 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.0 | 0.2 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.0 | 0.9 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
0.0 | 0.3 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
0.0 | 0.1 | GO:0009257 | 10-formyltetrahydrofolate biosynthetic process(GO:0009257) |
0.0 | 0.5 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
0.0 | 0.4 | GO:0043306 | positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
0.0 | 0.1 | GO:0072752 | cellular response to rapamycin(GO:0072752) |
0.0 | 0.5 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
0.0 | 0.8 | GO:0007173 | epidermal growth factor receptor signaling pathway(GO:0007173) |
0.0 | 0.4 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.0 | 1.2 | GO:0071549 | cellular response to dexamethasone stimulus(GO:0071549) |
0.0 | 0.1 | GO:0071409 | cellular response to cycloheximide(GO:0071409) |
0.0 | 0.5 | GO:0046039 | GTP metabolic process(GO:0046039) |
0.0 | 0.2 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.0 | 0.1 | GO:0071649 | regulation of chemokine (C-C motif) ligand 5 production(GO:0071649) positive regulation of chemokine (C-C motif) ligand 5 production(GO:0071651) |
0.0 | 0.1 | GO:0034454 | microtubule anchoring at centrosome(GO:0034454) |
0.0 | 0.7 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.0 | 0.1 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.0 | 0.4 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.0 | 0.6 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
0.0 | 1.9 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.0 | 1.5 | GO:0043647 | inositol phosphate metabolic process(GO:0043647) |
0.0 | 0.3 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.0 | 0.5 | GO:0045814 | negative regulation of gene expression, epigenetic(GO:0045814) |
0.0 | 0.3 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
0.0 | 0.2 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.0 | 0.3 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.0 | 0.2 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.0 | 0.1 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.0 | 0.0 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
0.0 | 0.0 | GO:1902725 | negative regulation of satellite cell differentiation(GO:1902725) |
0.0 | 0.3 | GO:0022038 | corpus callosum development(GO:0022038) |
0.0 | 0.3 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
0.0 | 0.2 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.0 | 0.2 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.0 | 0.7 | GO:0070423 | nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway(GO:0035872) nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) |
0.0 | 0.2 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.0 | 0.1 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
0.0 | 1.5 | GO:0045740 | positive regulation of DNA replication(GO:0045740) |
0.0 | 0.9 | GO:0021762 | substantia nigra development(GO:0021762) |
0.0 | 1.1 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
0.0 | 0.2 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.0 | 0.2 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
0.0 | 0.2 | GO:0072189 | ureter development(GO:0072189) |
0.0 | 0.4 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 4.5 | GO:0035838 | growing cell tip(GO:0035838) |
0.8 | 2.4 | GO:0043511 | inhibin complex(GO:0043511) inhibin A complex(GO:0043512) |
0.4 | 1.2 | GO:1990723 | cytoplasmic periphery of the nuclear pore complex(GO:1990723) |
0.3 | 1.3 | GO:0034676 | integrin alpha6-beta4 complex(GO:0034676) |
0.3 | 1.6 | GO:0032144 | 4-aminobutyrate transaminase complex(GO:0032144) |
0.2 | 4.2 | GO:0031209 | SCAR complex(GO:0031209) |
0.2 | 1.4 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
0.2 | 1.0 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
0.2 | 3.1 | GO:0016600 | flotillin complex(GO:0016600) |
0.2 | 1.1 | GO:0097513 | myosin II filament(GO:0097513) |
0.2 | 0.7 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.2 | 1.5 | GO:0044194 | cytolytic granule(GO:0044194) |
0.2 | 4.8 | GO:0005614 | interstitial matrix(GO:0005614) |
0.1 | 0.6 | GO:0031213 | RSF complex(GO:0031213) |
0.1 | 0.4 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.1 | 0.8 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.1 | 0.7 | GO:0071203 | WASH complex(GO:0071203) |
0.1 | 2.2 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.1 | 0.5 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.1 | 10.4 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.1 | 0.7 | GO:0033565 | ESCRT-0 complex(GO:0033565) |
0.1 | 1.7 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.1 | 1.2 | GO:0044309 | dendritic spine(GO:0043197) neuron spine(GO:0044309) |
0.1 | 0.4 | GO:0032279 | asymmetric synapse(GO:0032279) symmetric synapse(GO:0032280) |
0.1 | 1.1 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.1 | 1.8 | GO:0045180 | basal cortex(GO:0045180) |
0.1 | 1.0 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.1 | 1.1 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.1 | 0.6 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
0.1 | 0.7 | GO:0070852 | cell body fiber(GO:0070852) |
0.1 | 0.6 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.1 | 2.5 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.1 | 0.8 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
0.1 | 1.2 | GO:0033391 | chromatoid body(GO:0033391) |
0.1 | 1.2 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.1 | 2.6 | GO:0090544 | BAF-type complex(GO:0090544) |
0.1 | 1.5 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.1 | 1.2 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.1 | 1.8 | GO:0000242 | pericentriolar material(GO:0000242) |
0.0 | 0.6 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.0 | 0.6 | GO:0030681 | multimeric ribonuclease P complex(GO:0030681) |
0.0 | 0.4 | GO:0002177 | manchette(GO:0002177) |
0.0 | 1.3 | GO:0030056 | hemidesmosome(GO:0030056) |
0.0 | 0.2 | GO:0042585 | germinal vesicle(GO:0042585) |
0.0 | 2.0 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.0 | 0.1 | GO:0070877 | microprocessor complex(GO:0070877) ribonuclease III complex(GO:1903095) |
0.0 | 1.2 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.0 | 0.7 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.0 | 0.5 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.0 | 1.0 | GO:0043205 | microfibril(GO:0001527) fibril(GO:0043205) |
0.0 | 0.3 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
0.0 | 0.4 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.0 | 0.2 | GO:0005683 | U7 snRNP(GO:0005683) |
0.0 | 1.2 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
0.0 | 2.0 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.0 | 5.2 | GO:0055037 | recycling endosome(GO:0055037) |
0.0 | 1.7 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.0 | 0.7 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.0 | 1.1 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.0 | 0.6 | GO:0032433 | filopodium tip(GO:0032433) |
0.0 | 0.5 | GO:0030008 | TRAPP complex(GO:0030008) |
0.0 | 0.4 | GO:0005916 | fascia adherens(GO:0005916) |
0.0 | 0.5 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.0 | 2.4 | GO:0005871 | kinesin complex(GO:0005871) |
0.0 | 0.3 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.0 | 0.8 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.0 | 0.1 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
0.0 | 0.7 | GO:0071682 | endocytic vesicle lumen(GO:0071682) |
0.0 | 0.5 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.0 | 0.8 | GO:0016580 | Sin3 complex(GO:0016580) |
0.0 | 0.2 | GO:0034719 | SMN-Sm protein complex(GO:0034719) Gemini of coiled bodies(GO:0097504) |
0.0 | 1.5 | GO:0002102 | podosome(GO:0002102) |
0.0 | 0.2 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.0 | 0.3 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.0 | 2.8 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.0 | 0.5 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.0 | 1.0 | GO:0005876 | spindle microtubule(GO:0005876) |
0.0 | 0.2 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.0 | 0.1 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.0 | 0.9 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.0 | 0.2 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.0 | 1.3 | GO:0030532 | small nuclear ribonucleoprotein complex(GO:0030532) |
0.0 | 0.6 | GO:0044295 | axonal growth cone(GO:0044295) |
0.0 | 4.4 | GO:0030496 | midbody(GO:0030496) |
0.0 | 0.6 | GO:0030057 | desmosome(GO:0030057) |
0.0 | 1.9 | GO:0005770 | late endosome(GO:0005770) |
0.0 | 0.7 | GO:0030673 | axolemma(GO:0030673) |
0.0 | 0.3 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.0 | 0.4 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.0 | 1.5 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
0.0 | 0.4 | GO:0034451 | centriolar satellite(GO:0034451) |
0.0 | 1.3 | GO:0005844 | polysome(GO:0005844) |
0.0 | 0.4 | GO:0030904 | retromer complex(GO:0030904) |
0.0 | 0.4 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.0 | 1.8 | GO:0000502 | proteasome complex(GO:0000502) |
0.0 | 0.2 | GO:0033268 | node of Ranvier(GO:0033268) |
0.0 | 2.3 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.0 | 0.4 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.0 | 0.7 | GO:0016592 | mediator complex(GO:0016592) |
0.0 | 0.4 | GO:0042629 | mast cell granule(GO:0042629) |
0.0 | 0.0 | GO:0070931 | Golgi-associated vesicle lumen(GO:0070931) |
0.0 | 1.3 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.0 | 0.9 | GO:0000785 | chromatin(GO:0000785) |
0.0 | 0.2 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.0 | 0.1 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.0 | 0.3 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.0 | 0.5 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.0 | 0.2 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.0 | 0.9 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 0.1 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 4.5 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
1.0 | 4.8 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
0.5 | 4.8 | GO:0045545 | syndecan binding(GO:0045545) |
0.5 | 2.4 | GO:0047757 | chondroitin-glucuronate 5-epimerase activity(GO:0047757) |
0.4 | 2.4 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.4 | 1.2 | GO:0086040 | sodium:proton antiporter activity involved in regulation of cardiac muscle cell membrane potential(GO:0086040) |
0.4 | 3.2 | GO:0008865 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.3 | 1.3 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.3 | 1.0 | GO:0005365 | myo-inositol transmembrane transporter activity(GO:0005365) |
0.3 | 1.6 | GO:0032145 | 4-aminobutyrate transaminase activity(GO:0003867) succinate-semialdehyde dehydrogenase binding(GO:0032145) (S)-3-amino-2-methylpropionate transaminase activity(GO:0047298) |
0.3 | 1.1 | GO:0035501 | MH1 domain binding(GO:0035501) |
0.3 | 1.4 | GO:0004692 | cGMP-dependent protein kinase activity(GO:0004692) |
0.3 | 0.8 | GO:0036313 | phosphatidylinositol 3-kinase catalytic subunit binding(GO:0036313) |
0.3 | 1.3 | GO:0050659 | N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity(GO:0050659) |
0.2 | 2.2 | GO:0038049 | transcription factor activity, ligand-activated RNA polymerase II transcription factor binding(GO:0038049) |
0.2 | 0.8 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.2 | 2.2 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.2 | 0.6 | GO:0004379 | glycylpeptide N-tetradecanoyltransferase activity(GO:0004379) myristoyltransferase activity(GO:0019107) |
0.2 | 0.6 | GO:0046964 | 3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity(GO:0046964) |
0.2 | 2.6 | GO:0038132 | neuregulin binding(GO:0038132) |
0.2 | 0.5 | GO:0070119 | ciliary neurotrophic factor binding(GO:0070119) |
0.2 | 1.2 | GO:0047493 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
0.2 | 3.1 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.2 | 1.6 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.2 | 1.4 | GO:0015181 | arginine transmembrane transporter activity(GO:0015181) |
0.1 | 1.5 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.1 | 0.9 | GO:0046899 | nucleoside triphosphate adenylate kinase activity(GO:0046899) |
0.1 | 0.6 | GO:0005026 | transforming growth factor beta receptor activity, type II(GO:0005026) |
0.1 | 0.4 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) |
0.1 | 1.4 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.1 | 1.9 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.1 | 0.4 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.1 | 1.1 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) procollagen-proline dioxygenase activity(GO:0019798) |
0.1 | 1.7 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.1 | 0.5 | GO:0090556 | apolipoprotein A-I receptor activity(GO:0034188) phosphatidylserine-translocating ATPase activity(GO:0090556) |
0.1 | 0.6 | GO:0010465 | nerve growth factor receptor activity(GO:0010465) |
0.1 | 1.0 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) |
0.1 | 0.9 | GO:0035473 | lipase binding(GO:0035473) |
0.1 | 1.6 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.1 | 0.8 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.1 | 0.3 | GO:0008193 | tRNA guanylyltransferase activity(GO:0008193) |
0.1 | 1.2 | GO:0102336 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.1 | 0.3 | GO:0015091 | ferric iron transmembrane transporter activity(GO:0015091) trivalent inorganic cation transmembrane transporter activity(GO:0072510) |
0.1 | 0.8 | GO:0000828 | inositol-1,3,4,5,6-pentakisphosphate kinase activity(GO:0000827) inositol hexakisphosphate kinase activity(GO:0000828) inositol heptakisphosphate kinase activity(GO:0000829) inositol hexakisphosphate 5-kinase activity(GO:0000832) diphosphoinositol-pentakisphosphate kinase activity(GO:0033857) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.1 | 2.4 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.1 | 1.1 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.1 | 3.1 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.1 | 0.3 | GO:0036033 | mediator complex binding(GO:0036033) |
0.1 | 0.3 | GO:0030375 | thyroid hormone receptor activator activity(GO:0010861) thyroid hormone receptor coactivator activity(GO:0030375) |
0.1 | 1.1 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.1 | 1.0 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
0.1 | 1.3 | GO:0015217 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) ATP transmembrane transporter activity(GO:0005347) ADP transmembrane transporter activity(GO:0015217) |
0.1 | 0.3 | GO:0034647 | histone demethylase activity (H3-trimethyl-K4 specific)(GO:0034647) |
0.1 | 0.7 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.1 | 1.9 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.1 | 0.3 | GO:0035575 | histone demethylase activity (H4-K20 specific)(GO:0035575) |
0.1 | 0.6 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.1 | 1.0 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.1 | 2.2 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.1 | 0.5 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.1 | 0.4 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
0.1 | 1.3 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.1 | 1.0 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.1 | 0.9 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.1 | 0.1 | GO:1904713 | beta-catenin destruction complex binding(GO:1904713) |
0.1 | 0.3 | GO:0010736 | serum response element binding(GO:0010736) |
0.1 | 0.9 | GO:0030695 | GTPase regulator activity(GO:0030695) |
0.1 | 0.7 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.1 | 1.8 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.1 | 1.1 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.1 | 2.7 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.1 | 0.7 | GO:0030911 | TPR domain binding(GO:0030911) |
0.1 | 0.7 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.1 | 0.2 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.1 | 0.2 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.1 | 1.4 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.1 | 1.9 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.1 | 2.1 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.1 | 0.5 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.0 | 0.1 | GO:1904854 | proteasome core complex binding(GO:1904854) |
0.0 | 0.2 | GO:0004382 | guanosine-diphosphatase activity(GO:0004382) |
0.0 | 0.6 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
0.0 | 1.1 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.0 | 1.8 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.0 | 0.9 | GO:0016595 | glutamate binding(GO:0016595) |
0.0 | 1.6 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.0 | 1.4 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.0 | 1.0 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.0 | 0.6 | GO:0003700 | transcription factor activity, sequence-specific DNA binding(GO:0003700) |
0.0 | 1.4 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.0 | 0.1 | GO:0004483 | mRNA (nucleoside-2'-O-)-methyltransferase activity(GO:0004483) |
0.0 | 0.2 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.0 | 0.6 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
0.0 | 1.3 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.0 | 1.2 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.0 | 0.9 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.0 | 0.9 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.0 | 1.2 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.0 | 0.6 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.0 | 0.5 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.0 | 0.4 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.0 | 0.3 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
0.0 | 0.8 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.0 | 0.7 | GO:0070628 | proteasome binding(GO:0070628) |
0.0 | 0.3 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
0.0 | 1.3 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.0 | 0.1 | GO:0070984 | SET domain binding(GO:0070984) |
0.0 | 1.0 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.0 | 0.5 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.0 | 1.2 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.0 | 0.8 | GO:0036041 | long-chain fatty acid binding(GO:0036041) |
0.0 | 0.7 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.0 | 1.6 | GO:0061650 | ubiquitin conjugating enzyme activity(GO:0061631) ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
0.0 | 0.9 | GO:0031489 | myosin V binding(GO:0031489) |
0.0 | 0.3 | GO:0009374 | biotin binding(GO:0009374) |
0.0 | 4.7 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.0 | 0.2 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.0 | 0.1 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.0 | 0.5 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.0 | 0.5 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.0 | 0.2 | GO:0030274 | LIM domain binding(GO:0030274) |
0.0 | 1.5 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
0.0 | 0.7 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.0 | 1.2 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.0 | 0.4 | GO:0005537 | mannose binding(GO:0005537) |
0.0 | 0.3 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.0 | 2.0 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.0 | 2.0 | GO:0008028 | monocarboxylic acid transmembrane transporter activity(GO:0008028) |
0.0 | 1.1 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.0 | 0.2 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.0 | 6.0 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.0 | 1.5 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.0 | 0.4 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.0 | 0.6 | GO:0004659 | prenyltransferase activity(GO:0004659) |
0.0 | 0.1 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.0 | 1.2 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.0 | 0.1 | GO:0032296 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.0 | 0.3 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.0 | 0.9 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.0 | 0.1 | GO:0004329 | formate-tetrahydrofolate ligase activity(GO:0004329) |
0.0 | 0.2 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.0 | 0.1 | GO:0030371 | translation repressor activity, nucleic acid binding(GO:0000900) translation repressor activity(GO:0030371) translation regulator activity, nucleic acid binding(GO:0090079) |
0.0 | 0.3 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.0 | 0.4 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.0 | 0.1 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.0 | 0.3 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.0 | 1.7 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.0 | 1.4 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.0 | 0.7 | GO:0019707 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
0.0 | 0.1 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.0 | 0.1 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.0 | 2.5 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.0 | 0.1 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.0 | 0.1 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.0 | 0.5 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.0 | 1.9 | GO:0019903 | protein phosphatase binding(GO:0019903) |
0.0 | 0.6 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
0.0 | 0.2 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.0 | 0.6 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.0 | 1.0 | GO:0019003 | GDP binding(GO:0019003) |
0.0 | 0.0 | GO:0003880 | protein C-terminal carboxyl O-methyltransferase activity(GO:0003880) |
0.0 | 0.5 | GO:0015248 | sterol transporter activity(GO:0015248) |
0.0 | 0.9 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.0 | 0.2 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.0 | 0.6 | GO:0008378 | galactosyltransferase activity(GO:0008378) |
0.0 | 0.1 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.0 | 0.2 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.0 | 0.4 | GO:0071949 | FAD binding(GO:0071949) |
0.0 | 0.2 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.0 | 0.2 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 5.5 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.1 | 2.6 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.1 | 4.5 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.1 | 1.3 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.1 | 3.4 | PID ALK1 PATHWAY | ALK1 signaling events |
0.1 | 5.9 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.1 | 5.6 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.1 | 1.2 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.1 | 2.7 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.0 | 2.4 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.0 | 2.6 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.0 | 2.1 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.0 | 5.6 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.0 | 0.9 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.0 | 5.0 | PID NOTCH PATHWAY | Notch signaling pathway |
0.0 | 3.3 | PID RHOA PATHWAY | RhoA signaling pathway |
0.0 | 3.0 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.0 | 2.1 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.0 | 1.6 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.0 | 0.5 | ST STAT3 PATHWAY | STAT3 Pathway |
0.0 | 0.5 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.0 | 1.9 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.0 | 1.3 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.0 | 0.1 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.0 | 1.1 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.0 | 0.2 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.0 | 0.4 | PID MYC PATHWAY | C-MYC pathway |
0.0 | 0.4 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.0 | 1.5 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.0 | 0.4 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.0 | 1.4 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 5.1 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.2 | 0.2 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.2 | 3.9 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.1 | 3.8 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.1 | 2.4 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.1 | 1.2 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.1 | 1.9 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.1 | 4.0 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.1 | 1.2 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.1 | 2.0 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.1 | 2.1 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.1 | 0.7 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.1 | 4.4 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.1 | 1.0 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.1 | 0.6 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.1 | 4.1 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.1 | 0.2 | REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
0.1 | 1.5 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.1 | 1.4 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.1 | 0.8 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.0 | 1.3 | REACTOME INCRETIN SYNTHESIS SECRETION AND INACTIVATION | Genes involved in Incretin Synthesis, Secretion, and Inactivation |
0.0 | 1.4 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 2.1 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.0 | 2.2 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.0 | 1.1 | REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
0.0 | 2.0 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.0 | 1.0 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.0 | 0.9 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.0 | 1.2 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.0 | 1.4 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.0 | 0.5 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.0 | 2.0 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.0 | 1.4 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.0 | 2.7 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.0 | 0.7 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.0 | 1.1 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.0 | 0.5 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.0 | 3.6 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.0 | 1.5 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.0 | 0.7 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.0 | 2.2 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.0 | 1.2 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.0 | 0.7 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.0 | 0.9 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.0 | 0.1 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.0 | 0.3 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.0 | 0.1 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.0 | 1.5 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.0 | 0.3 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.0 | 1.0 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.0 | 0.7 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.0 | 2.4 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.0 | 0.2 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.0 | 0.5 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.0 | 0.3 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.0 | 0.7 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.0 | 0.2 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |